01—Abstract
Summary
Summary of the 8-K filed May 23, 2024. Cited figures are marked; the original filing is the authoritative source.
Tenet Healthcare Corporation reported in this Form 8-K, filed May 23, 2024, the final voting results from its 2024 Annual Meeting of Shareholders, held May 22, 2024.
Shareholders elected all 13 nominated directors, each to serve until the next annual meeting or until a successor is duly elected or qualified. Each nominee received a majority of votes cast FOR, with the largest AGAINST tally being 2,952,599 for Saumya Sutaria. Shareholders also approved, on an advisory basis, the company's executive compensation, with 78,324,154 votes FOR and 2,920,906 AGAINST, and ratified Deloitte & Touche LLP as independent registered public accountants for the year ending December 31, 2024, with 87,988,280 votes FOR and 496,790 AGAINST.
Two shareholder proposals did not pass: one requesting a report on risk mitigation regarding state restrictions for emergency abortions (4,059,525 FOR, 75,912,077 AGAINST) and one requesting a report on plans to integrate ESG metrics into executive compensation (4,328,821 FOR, 76,596,569 AGAINST). For investors, the filing reflects a shareholder base that supported board nominees, management's pay program, and the auditor, and that rejected both shareholder proposals by wide margins. The filing does not describe any other corporate actions.
02—Key points
Key Highlights
- The 2024 Annual Meeting of Shareholders was held May 22, 2024.
- All 13 directors were elected, including Saumya Sutaria, J. Robert Kerrey, Vineeta Agarwala, James L. Bierman, Roy Blunt, Richard W. Fisher, Meghan M. FitzGerald, Cecil D. Haney, Christopher S. Lynch, Richard J. Mark, Tammy Romo, Stephen H. Rusckowski, and Nadja Y. West.
- Shareholders approved, on an advisory basis, the company's executive compensation: 78,324,154 FOR, 2,920,906 AGAINST, 147,662 ABSTAIN.
- Shareholders ratified Deloitte & Touche LLP as independent registered public accountants for the year ending December 31, 2024: 87,988,280 FOR, 496,790 AGAINST, 34,996 ABSTAIN.
- A shareholder proposal requesting a report on risk mitigation regarding state restrictions for emergency abortions did not pass: 4,059,525 FOR, 75,912,077 AGAINST.
- A shareholder proposal requesting a report on plans to integrate ESG metrics into executive compensation did not pass: 4,328,821 FOR, 76,596,569 AGAINST.
- Broker non-votes were 7,127,343 on each director and proposal item where they applied.
03—Questions
Frequently Asked Questions
Who was elected to Tenet's Board of Directors at the 2024 Annual Meeting?
Thirteen directors were elected: Saumya Sutaria, J. Robert Kerrey, Vineeta Agarwala, James L. Bierman, Roy Blunt, Richard W. Fisher, Meghan M. FitzGerald, Cecil D. Haney, Christopher S. Lynch, Richard J. Mark, Tammy Romo, Stephen H. Rusckowski, and Nadja Y. West. Each will serve until the next annual meeting or until a successor is duly elected or qualified, or until earlier resignation or removal.
Did shareholders approve the executive compensation program?
Yes. On an advisory basis, shareholders approved the company's executive compensation with 78,324,154 votes FOR, 2,920,906 AGAINST, and 147,662 ABSTAIN.
Who was ratified as Tenet's independent auditor?
Shareholders ratified Deloitte & Touche LLP as independent registered public accountants for the year ending December 31, 2024, with 87,988,280 votes FOR, 496,790 AGAINST, and 34,996 ABSTAIN.
Did any shareholder proposals pass at the meeting?
No. The proposal requesting a report on risk mitigation regarding state restrictions for emergency abortions received 4,059,525 FOR and 75,912,077 AGAINST. The proposal requesting a report on integrating ESG metrics into executive compensation received 4,328,821 FOR and 76,596,569 AGAINST. Neither passed.
04—Continue